Ashish Upadhyay, MD
Associate Professor
Boston University School of Medicine
Dept of Medicine

MBBS, Tribhuvan University

Dr. Upadhyay is a board-certified nephrologist with academic interests in examining the mechanisms of cardiovascular disease in patients with chronic kidney disease (CKD), hemodialysis systems, and evidence-based medicine (EBM). He has conducted epidemiologic research in the Framingham Heart Study, led the evidence review team for the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on lipid management in CKD, and participated in the evidence review teams for the KDIGO clinical practice guidelines on blood pressure management in CKD and anemia management in CKD. He maintains an active clinical practice in general nephrology, hemodialysis, and peritoneal dialysis, and is the Program Director of BU's Nephrology Fellowship Training Program. In addition, he directs research and EBM curriculum of BU's Internal Medicine Residency Program, and was an Associate Program Director of the Internal Medicine Residency Program from 2012 to 2018. Outside of BU, Dr. Upadhyay serves as a voting member of the Association for the Advancement of Medical Instrumentation (AAMI)’s Renal Disease and Detoxification Committee, the primary source of national and international consensus standards for hemodialysis technology and dialysis water sterilization processes.

Program Director
Boston University School of Medicine
Nephrology Fellowship Program

Director, Scholarship and EBM
Boston University School of Medicine
Internal Medicine Residency Program

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Toth PP, Dwyer JP, Cannon CP, Colhoun HM, Rader DJ, Upadhyay A, Louie MJ, Koren A, Letierce A, Mandel J, Banach M. Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. Kidney Int. 2018 06; 93(6):1397-1408. PMID: 29526502.
  2. Upadhyay A, Susantitaphong P, Jaber BL. Ultrapure versus standard dialysate: A cost-benefit analysis. Semin Dial. 2017 09; 30(5):398-402. PMID: 28608933; DOI: 10.1111/sdi.12618;.
  3. Chen C, Upadhyay A. Renal denervation for uncontrolled hypertension: critical review of the evidence. Curr Opin Nephrol Hypertens. 2017 Mar; 26(2):114-122.View Related Profiles. PMID: 27922849; DOI: 10.1097/MNH.0000000000000300;.
  4. Upadhyay A, Jaber BL. Reuse and Biocompatibility of Hemodialysis Membranes: Clinically Relevant? Semin Dial. 2017 Mar; 30(2):121-124. PMID: 28066932; DOI: 10.1111/sdi.12574;.
  5. Upadhyay A, Jaber BL. We Use Impure Water to Make Dialysate for Hemodialysis. Semin Dial. 2016 Jul; 29(4):297-9. PMID: 27061684; DOI: 10.1111/sdi.12493;.
  6. Stillman MD, Miller KH, Ziegler CH, Upadhyay A, Mitchell CK. Program Characteristics Influencing Allopathic Students' Residency Selection. J Am Osteopath Assoc. 2016 Apr; 116(4):214-26. PMID: 27018956; DOI: 10.7556/jaoa.2016.046;.
  7. Upadhyay A, Inker LA, Levey AS. Chronic Kidney Disease: Definition, Classification and Approach to Management. Goldsmith D, Section editor. Oxford Textbook of Clinical Nephrology. Oxford University Press. Oxford, UK. 2015; 743-754.
  8. Wang K, Upadhyay A. Sugar-sweetened Beverages and Chronic Kidney Disease. US Endocrinology. 2015; 1(11):41-45; DOI: 10.17925/USE.2015. View Publication
  9. Upadhyay A. Statins in chronic kidney disease: what do meta-analyses tell us? Clin Exp Nephrol. 2014 Apr; 18(2):278-81. PMID: 24158229; DOI: 10.1007/s10157-013-0889-2;.
  10. Roseman DA, Hwang SJ, Manders ES, O'Donnell CJ, Upadhyay A, Hoffmann U, Fox CS. Renal artery calcium, cardiovascular risk factors, and indexes of renal function. Am J Cardiol. 2014 Jan 1; 113(1):156-61.View Related Profiles. PMID: 24210678; PMCID: PMC3882167; DOI: 10.1016/j.amjcard.2013.09.036;.
Showing 10 of 34 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 34 publications over 13 distinct years, with a maximum of 5 publications in 2011 and 2012

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Chronic Kidney Disease
Vascular Disease Risk Factors

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

Renal Section, Evans Biomedical Research Building - 650 Albany Street, Suite 5A
Boston MA 02118
Google Map

Upadhyay's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department